Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950136-04-000446
Filing Date
2004-02-17
Accepted
2004-02-17 16:36:38
Documents
1
Group Members
APAX EUROPE IV GP CO. LIMITEDAPAX EUROPE IV, GP L.P.APAX ISRAEL GP INC.APAX ISRAEL PARTNERS II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G file001.txt SC 13G/A 23710
  Complete submission text file 0000950136-04-000446.txt   25649
Mailing Address
Business Address 72 PINCHAS ROSEN ST TEL AVIV TEL AVIV L3 69512 011-972-3-765-8585
COMPUGEN LTD (Subject) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60609 | Film No.: 04609333
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 15 PORTLAND PLACE LONDON UK X0 W1B 1PT
Business Address 15 PORTLAND PLACE LONDON ENGLAND X0 W1B 1PT
APAX EUROPE IV GP CO LTD (Filed by) CIK: 0001167510 (see all company filings)

State of Incorp.: DE